Kurs
+9,45%
Kalender
Est. tid* | ||
2026-03-03 | 08:30 | Bokslutskommuniké 2025 |
2025-11-04 | 08:30 | Kvartalsrapport 2025-Q3 |
2025-08-12 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-05-14 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2025-05-13 | - | Årsstämma |
2025-05-06 | - | Kvartalsrapport 2025-Q1 |
2025-03-04 | - | Bokslutskommuniké 2024 |
2024-11-05 | - | Kvartalsrapport 2024-Q3 |
2024-08-13 | - | Kvartalsrapport 2024-Q2 |
2024-05-15 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2024-05-14 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-03-05 | - | Bokslutskommuniké 2023 |
2023-10-17 | - | Kvartalsrapport 2023-Q3 |
2023-08-15 | - | Kvartalsrapport 2023-Q2 |
2023-05-25 | - | Kvartalsrapport 2023-Q1 |
2023-05-17 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2023-05-16 | - | Årsstämma |
2023-03-07 | - | Bokslutskommuniké 2022 |
2022-11-22 | - | Kvartalsrapport 2022-Q3 |
2022-08-16 | - | Kvartalsrapport 2022-Q2 |
2022-05-25 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2022-05-24 | - | Årsstämma |
2022-05-03 | - | Kvartalsrapport 2022-Q1 |
2022-03-08 | - | Bokslutskommuniké 2021 |
2021-11-02 | - | Kvartalsrapport 2021-Q3 |
2021-08-17 | - | Kvartalsrapport 2021-Q2 |
2021-05-25 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2021-05-24 | - | Årsstämma |
2021-05-04 | - | Kvartalsrapport 2021-Q1 |
2021-03-08 | - | Bokslutskommuniké 2020 |
2020-11-11 | - | Kvartalsrapport 2020-Q3 |
2020-08-18 | - | Kvartalsrapport 2020-Q2 |
2020-05-20 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2020-05-19 | - | Årsstämma |
2020-05-13 | - | Kvartalsrapport 2020-Q1 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2019-11-12 | - | Kvartalsrapport 2019-Q3 |
2019-08-12 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-03-19 | - | Extra Bolagsstämma 2019 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-11-15 | - | Kvartalsrapport 2018-Q3 |
2018-08-15 | - | Kvartalsrapport 2018-Q2 |
2018-05-15 | - | Extra Bolagsstämma 2018 |
2018-05-15 | - | Kvartalsrapport 2018-Q1 |
2018-03-01 | - | X-dag ordinarie utdelning CMOTEC B 0.00 SEK |
2018-02-28 | - | Årsstämma |
2018-01-30 | - | Bokslutskommuniké 2017 |
2017-05-31 | - | Extra Bolagsstämma 2017 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Following successful final tests Scandinavian ChemoTech, along with its partner in electrode technology, has developed CE-marked treatment kits for deep-seated tumours.
The Company's new treatment kits are primarily developed for the treatment of deep-seated tumours. These have now passed the important compatibility tests between the new electrodes and our TSE™ technology. These new kits are intended for use in both human and veterinary medicine.
"It feels very good to have been able to secure access to CE-marked treatment kits even for deep-seated tumours. This enables us to now begin clinical trials on these kinds of tumours, which in significant ways may change the conditions for both ChemoTech and Vetiqure." - says Mohan Frick, CEO Scandinavian ChemoTech
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-10-2021 09:30 CET.
Mohan Frick, CEO
Phone: +46 (0)10-218 93 00
info@chemotech.se
Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: certifiedadviser@penser.se